Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

Nutanix, Inc.

NTNX
Technology · Software - Infrastructure

Nutanix, Inc.'s balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.

Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding.

The price is topping out (6 weeks in) while the P/E sits at the 59th percentile of its own 1-year range. But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.

Price
$61.5
−14.7% 1Y
P/E
64.4×
59th pctile
of its own 1-year range
Revenue (Apr 26)
$0.4 B
+2.9% YoY
Profit (Apr 26)
$0.1 B
+16.7% YoY
Operating margin
19.4%
+5.1 pp YoY
ROIC
12.5%
vs WACC 7.0% → +5.5 pp
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Nutanix, Inc. trades at $61.5, losing momentum at the top and 6 weeks into that stage. That is +25.1% against its own 200-day average. It sits at 60% of a 52-week range of $34 to $79. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 15 straight weeks.

Today the stock is losing momentum at the top — week 6 of stage 3. At $61.5 it trades +25.1% versus its 200-day average and sits at 60% of its 52-week range ($34–$79).

Aug 26: $61.5 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+25.1% versus the 200-day line, week 6 of stage 3
Price50-day avg200-day avg
S2S2S2S1S4$87.2$71.1$55.0$39.0$22.9$$62$49Jul 23Apr 24Jan 25Oct 25Aug 26
S2S2S2S1S4$87.2$71.1$55.0$39.0$22.9$$62$49Jul 23Jan 25Aug 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (514 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Oct 16Aug 26

Against the market, two honest reads. Cumulative: over the last 9.8 years the stock moved +61% while the S&P 500 moved +259% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 15 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Nutanix, Inc. trades at 64.4× P/E, mid-range by its own standards (59th percentile). Its long-run median P/E is 59.5×, measured across 1.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 64.4× is mid-range by its own standards (59th percentile), against a long-run median of 59.5× measured over 1.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 64.4× vs a 59.5× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 1.0-year window; loss-period spikes above 121× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
mid-range by its own standards (59th percentile)
P/EMedianEPS (TTM) (quarterly)
127.1×$1.0103.0×$0.878.9×$0.554.9×$0.330.8×$0.0×$64.74×$1Aug 25Oct 25Jan 26May 26Aug 26
127.1×$1.0103.0×$0.878.9×$0.554.9×$0.330.8×$0.0×$64.74×$1Aug 25Jan 26Aug 26
PEG 1.93 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 15 quarters; values above 6 pinned at the top.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
6.4×5.0×3.5×2.0×0.6××1.93×Oct 22Jul 23Jul 24Apr 25Apr 26
6.4×5.0×3.5×2.0×0.6××1.93×Oct 22Jul 24Apr 26
P/E
64.4×
59th percentile of 1y
PEG
2.68
as reported

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Nutanix, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 1 curve, on partial evidence.

Growth, year by year: revenue +18.1% in FY25 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoY
18%17%16%15%13%%18.1%FY21FY23FY25
18%17%16%15%13%%18.1%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising
RevenueProfit
21%107%13%83%4.4%58%−4.1%34%−13%10%%%−2.3%16.7%Jul 23Oct 24Apr 26
21%107%13%83%4.4%58%−4.1%34%−13%10%%%−2.3%16.7%Jul 23Oct 24Apr 26
Revenue growth
Flat
latest −2.3% · span −10.2% to +19.0%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+18.1%+17.1%
Stock price−14.7%+27.6%+10.9%
Revenue YoY (Apr 26)
+2.9%
latest quarter vs a year ago
Profit YoY (Apr 26)
+16.7%
latest quarter vs a year ago
Revenue 10y
16.3%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

50.6/100 — rank 13 of 28 in Software - Infrastructure · 75% evidence confidence

Nutanix, Inc. scores 50.6 out of 100 against the 28 companies it is compared with in Software - Infrastructure, ranking 13. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 19 + 11 + 9.8 + 10.8 = 50.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Nutanix, Inc. reported $0.4 B of revenue in the Apr 26 quarter, +2.9% year on year. That is the 3rd straight quarter of year-on-year growth. Over 4 years it has compounded at 16.3% a year. The last full year, FY25, came in at $2.5 B. The last four reported quarters add to $2.1 B.

FY25 revenue came in at $2.5 B (+18.1% on the year), capping 4 years at 16.3% compound. The latest quarter (Apr 26) printed $0.4 B, +2.9% year on year — the 3rd consecutive quarter of year-over-year growth.

FY25 revenue $2.5 B (+18.1% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
16.3% a year over 4 years
RevenueYoY growth
2.718%2.117%1.416%0.715%0.013%$ B%$3B18.1%FY21FY23FY25
2.718%2.117%1.416%0.715%0.013%$ B%$3B18.1%FY21FY23FY25
Apr 26: $0.4 B (+2.9% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
3rd straight quarter of growth
Revenue (quarterly)YoY growth
0.831%0.612%0.4−6.3%0.2−25%0.0−43%$ B%$0B2.9%Jul 23Oct 24Apr 26
0.831%0.612%0.4−6.3%0.2−25%0.0−43%$ B%$0B2.9%Jul 23Oct 24Apr 26

Pace check: the last four quarters averaged −2.7% growth against the decade's 16.3% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew −2.3% over the last 4 quarters against +0.0%/yr over the last 8 — stabilising.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Nutanix, Inc.'s operating margin is 19.4% in the Apr 26 quarter, +5.1 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged −47.5% to 6.7%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 19.4%, +5.1 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −47.5%–6.7%, and FY25's 6.7% is the top of that band — a record year.

Why the margin moved: operating margin went +5.1 pp year on year while gross margin went +9.4 pp — the gain came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY25: 6.7% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
the widest a −47.5–6.7% band over 5 years
operating marginYoY change (pp)
11%19%−4.7%16%−20%12%−36%8.8%−52%5.2%%%6.7%6.2%FY21FY23FY25
11%19%−4.7%16%−20%12%−36%8.8%−52%5.2%%%6.7%6.2%FY21FY23FY25
Apr 26: 19.4% operating margin (+5.1 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
21%34%15%25%8.7%16%2.5%6.7%−3.7%−2.3%%%19.4%5.1%Jul 23Oct 24Apr 26
21%34%15%25%8.7%16%2.5%6.7%−3.7%−2.3%%%19.4%5.1%Jul 23Oct 24Apr 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Nutanix, Inc. earned $0.1 B of net profit in the Apr 26 quarter, +16.7% year on year. It is the 3rd consecutive quarter of growth. Full-year FY25 profit was $0.2 B. That is 19.4% of the quarter's revenue. The same quarter a year earlier earned $0.1 B. 4 of the last 12 reported quarters were loss-making.

Apr 26 profit was $0.1 B, +16.7% year on year — the 3rd consecutive quarter of growth. On the full year, FY25 printed $0.2 B (null).

FY25 profit $0.2 B (null YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profit
0.3−0.1−0.4−0.8−1.1$ B$0BFY21FY23FY25
0.3−0.1−0.4−0.8−1.1$ B$0BFY21FY23FY25
Apr 26: $0.1 B (+16.7% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
3rd straight quarter of growth
Net profit (quarterly)YoY growth
0.12107%0.0583%−0.0258%−0.0834%−0.1510%$ B%$0B16.7%Jul 23Oct 24Apr 26
0.12107%0.0583%−0.0258%−0.0834%−0.1510%$ B%$0B16.7%Jul 23Oct 24Apr 26

Why profit moved: revenue contributed +2.9% and the margin +5.1 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.

Pace comparison, last four quarters: profit +61.1% vs revenue −2.7%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Nutanix, Inc.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.8 B of operating cash against $0.2 B of profit. After $0.1 B of capital spending, $0.8 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $0.8 B against reported profit of $0.2 B, leaving free cash of $0.8 B after $0.1 B of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $0.8 B vs profit $0.2 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
Operating cashNet profitFree cash
1.00.4−0.1−0.6−1.2$ B$1B$0B$1BFY21FY23FY25
1.00.4−0.1−0.6−1.2$ B$1B$0B$1BFY21FY23FY25
Apr 26: operating cash $0.2 B = 300% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.26676%0.19521%0.13367%0.06212%0.0057%$ B%$0B300%Jul 23Oct 24Apr 26
0.26676%0.19521%0.13367%0.06212%0.0057%$ B%$0B300%Jul 23Oct 24Apr 26

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Nutanix, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.1 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.090.060.040.020.00$ B$0BFY21FY23FY25
0.090.060.040.020.00$ B$0BFY21FY23FY25
Apr 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.0320.230.0240.180.0160.140.0080.090.0000.04$ B$ B$0B$0BJul 23Oct 24Apr 26
0.0320.230.0240.180.0160.140.0080.090.0000.04$ B$ B$0B$0BJul 23Oct 24Apr 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Nutanix, Inc. earns a ROE of −28% in FY25. Return on invested capital clears the cost of that capital by +5.5 percentage points, so growth here adds value rather than only size. The wiring behind it is 7.5% net margin on 0.77× asset turns.

FY25 ROE is −28%.

Why the return is what it is — the wiring (FY25): 7.5% net margin × 0.77× asset turns × −4.75× balance-sheet leverage ≈ −27.4% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 12.5% − 7.0% = a +5.5 pp spread. The 7.0% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.

FY25: ROE −28% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 7.0% cost of capital used on this page.
the full ladder
ROEROIC (annual)WACC
116%69%23%−24%−70%%−27.5%11.1%FY21FY23FY25
116%69%23%−24%−70%%−27.5%11.1%FY21FY23FY25
Apr 26: ROIC 12.1% (TTM) vs WACC 7.0% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
40%19%−1.6%−22%−43%%12.1%−37.2%Jul 23Oct 24Apr 26
40%19%−1.6%−22%−43%%12.1%−37.2%Jul 23Oct 24Apr 26
11 · Dividend

Dividend

Nutanix, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Nutanix, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Nutanix, Inc.'s net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from −1.17 in FY21 to −2.14 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Apr 26: total debt of $1.5 B against shareholder equity of $−0.7 B — a debt-to-equity of −2.10. On the annual view, debt-to-equity went from −1.17 (FY21) to −2.14 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $1.5 B at −2.14× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
1.6−0.8×1.2−1.2×0.8−1.5×0.4−1.9×0.0−2.2×$ B×$2B−2.14×FY21FY23FY25
1.6−0.8×1.2−1.2×0.8−1.5×0.4−1.9×0.0−2.2×$ B×$2B−2.14×FY21FY23FY25
Apr 26: debt $1.5 B, debt-to-equity −2.10 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
1.7−0.8×1.2−1.2×0.8−1.6×0.4−1.9×0.0−2.3×$ B×$2B−2.10×Jul 23Oct 24Apr 26
1.7−0.8×1.2−1.2×0.8−1.6×0.4−1.9×0.0−2.3×$ B×$2B−2.10×Jul 23Oct 24Apr 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

10.3% of Nutanix, Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 6.5 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 10.3% of the float is sold short, and at typical trading volumes it would take about 6.5 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
10.3%
of the tradable float
Days to cover
6.5
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Nutanix, Inc.: the Z-score reads 1.76. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

🚨 Why it matters: a Z-score of 1.76 is inside the distress zone — the balance sheet is a real risk, not a detail.

The safety line in one sentence: the Z-score reads 1.76.

15 · Related companies · Software - Infrastructure
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Fortinet, Inc.FTNT 67.2/100Thin evidence · provisional58% evidence LEADER 21.4/35 Revenue — · PAT — · OPM change 1.9 pp 45% evidence 17.8/25 ROCE 11.6% · OPM 31.4% 76% evidence 9.4/20 P/E 54.1× · PEG — 15% evidence 18.6/20 RS sector 39.5% · RS bench 54.1% · 1Y 126.2%12 of 12 weeks ahead 100% evidence
Exact sum: 21.4 + 17.8 + 9.4 + 18.6 = 67.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
2NetApp, Inc.NTAP 65.4/100Favorable setup85% evidence LEADER 19.4/35 Revenue 5.4% · PAT 7.6% · OPM change 7.2 pp 95% evidence 16.1/25 ROCE 8.3% · OPM 27.3% 76% evidence 11.9/20 P/E 17.1× · PEG 1.43 65% evidence 18.0/20 RS sector 27.3% · RS bench 40.7% · 1Y 79.3%12 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 16.1 + 11.9 + 18 = 65.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Corpay, Inc.CPAY 62.9/100Mixed-positive evidence81% evidence BREAKING OUT 21.9/35 Revenue 18.2% · PAT 16.1% · OPM change 7.9 pp 83% evidence 15.2/25 ROCE 5.8% · OPM 50.4% 76% evidence 14.3/20 P/E 17.4× · PEG 1.01 65% evidence 11.5/20 RS sector -0.1% · RS bench 11.2% · 1Y 31.4%5 of 12 weeks ahead 100% evidence
Exact sum: 21.9 + 15.2 + 14.3 + 11.5 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4VeriSign, Inc.VRSN 60.5/100Thin evidence · provisional58% evidence BASING 22.2/35 Revenue — · PAT — · OPM change 1.1 pp 45% evidence 21.6/25 ROCE 1141.8% · OPM 68.5% 76% evidence 10.6/20 P/E 27.3× · PEG — 15% evidence 6.1/20 RS sector -7.4% · RS bench 2.9% · 1Y 10%4 of 12 weeks ahead 100% evidence
Exact sum: 22.2 + 21.6 + 10.6 + 6.1 = 60.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5Palantir Technologies Inc.PLTR 60.0/100Mixed-positive evidence71% evidence TURNING 29.3/35 Revenue 67.7% · PAT 100% · OPM change 26.3 pp 83% evidence 15.9/25 ROCE 10.3% · OPM 46.2% 76% evidence 8.9/20 P/E 164.4× · PEG — 15% evidence 5.9/20 RS sector -15.6% · RS bench -6.3% · 1Y -13.1%1 of 12 weeks ahead 100% evidence
Exact sum: 29.3 + 15.9 + 8.9 + 5.9 = 60 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -15.6% and the one-year return is -13.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
6CrowdStrike Holdings, Inc.CRWD 55.7/100Mixed-positive evidence67% evidence LEADER 22.2/35 Revenue 23.2% · PAT — · OPM change 8.6 pp 71% evidence 6.5/25 ROCE -0.5% · OPM -2.2% 76% evidence 8.5/20 P/E 582.1× · PEG — 15% evidence 18.5/20 RS sector 32.3% · RS bench 46% · 1Y 99%12 of 12 weeks ahead 100% evidence
Exact sum: 22.2 + 6.5 + 8.5 + 18.5 = 55.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Okta, Inc.OKTA 54.4/100Mixed-positive evidence75% evidence BREAKING OUT 18.1/35 Revenue 11.8% · PAT 90% · OPM change 1.6 pp 95% evidence 8.2/25 ROCE 0.8% · OPM 7.3% 76% evidence 9.5/20 P/E 53.4× · PEG — 15% evidence 18.6/20 RS sector 27.6% · RS bench 40.8% · 1Y 61.6%12 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 8.2 + 9.5 + 18.6 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8F5, Inc.FFIV 53.7/100Thin evidence · provisional58% evidence LEADER 16.7/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence 14.2/25 ROCE 4.4% · OPM 22.1% 76% evidence 10.5/20 P/E 33.1× · PEG — 15% evidence 12.3/20 RS sector 6.8% · RS bench 18.3% · 1Y 28.1%12 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 14.2 + 10.5 + 12.3 = 53.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9Toast, Inc.TOST 53.2/100Mixed-positive evidence71% evidence TURNING 25.0/35 Revenue 23.4% · PAT 100% · OPM change 3.5 pp 83% evidence 10.7/25 ROCE 5.9% · OPM 6.7% 76% evidence 9.9/20 P/E 40.8× · PEG — 15% evidence 7.6/20 RS sector -15.1% · RS bench -6% · 1Y -21.5%2 of 12 weeks ahead 100% evidence
Exact sum: 25 + 10.7 + 9.9 + 7.6 = 53.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10GoDaddy Inc.GDDY 52.0/100Thin evidence · provisional58% evidence ASLEEP 21.2/35 Revenue — · PAT — · OPM change 3.8 pp 45% evidence 15.3/25 ROCE 6.8% · OPM 24.5% 76% evidence 11.4/20 P/E 12.6× · PEG — 15% evidence 4.1/20 RS sector -33% · RS bench -26% · 1Y -33.2%1 of 12 weeks ahead 100% evidence
Exact sum: 21.2 + 15.3 + 11.4 + 4.1 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Microsoft CorporationMSFT 51.5/100Thin evidence · provisional58% evidence TURNING 16.7/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence 16.2/25 ROCE 7.6% · OPM 46.3% 76% evidence 10.8/20 P/E 20.8× · PEG — 15% evidence 7.8/20 RS sector -11.2% · RS bench -1.5% · 1Y -5.6%2 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 16.2 + 10.8 + 7.8 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12DigitalOcean Holdings, Inc.DOCN 51.2/100Mixed-positive evidence71% evidence FADING 16.8/35 Revenue 17.7% · PAT 100% · OPM change -3.7 pp 83% evidence 10.7/25 ROCE 2.2% · OPM 14.2% 76% evidence 10.4/20 P/E 37.5× · PEG — 15% evidence 13.3/20 RS sector 35.2% · RS bench 50.5% · 1Y 290%11 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 10.7 + 10.4 + 13.3 = 51.2 · Decision use: Price leads the evidence: RS versus the benchmark is 50.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
13Nutanix, Inc.this pageNTNX 50.6/100Mixed-positive evidence75% evidence BREAKING OUT 19.0/35 Revenue -1.9% · PAT 100% · OPM change 5.2 pp 95% evidence 11.0/25 ROCE 3.7% · OPM 19.3% 76% evidence 9.8/20 P/E 43× · PEG — 15% evidence 10.8/20 RS sector -6.3% · RS bench 2.9% · 1Y -14.1%11 of 12 weeks ahead 100% evidence
Exact sum: 19 + 11 + 9.8 + 10.8 = 50.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Rubrik, Inc.RBRK 50.1/100Mixed-positive evidence64% evidence BREAKING OUT 25.7/35 Revenue 45.9% · PAT — · OPM change 19.8 pp 71% evidence 3.1/25 ROCE -5.3% · OPM -13.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 11.3/20 RS sector -5.3% · RS bench 4.2% · 1Y -7.3%12 of 12 weeks ahead 100% evidence
Exact sum: 25.7 + 3.1 + 10 + 11.3 = 50.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Samsara Inc.IOT 49.3/100Mixed-negative evidence67% evidence BREAKING OUT 24.5/35 Revenue 29.6% · PAT — · OPM change 10.6 pp 71% evidence 7.1/25 ROCE 0.5% · OPM 1.5% 76% evidence 8.6/20 P/E 304.9× · PEG — 15% evidence 9.1/20 RS sector -9.4% · RS bench 0.2% · 1Y 14.4%7 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 7.1 + 8.6 + 9.1 = 49.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Gen Digital Inc.GEN 48.8/100Mixed-negative evidence74% evidence BREAKING OUT 17.4/35 Revenue 27.1% · PAT 51.3% · OPM change -6.4 pp 62% evidence 15.8/25 ROCE 6.3% · OPM 62.6% 76% evidence 7.1/20 P/E 12× · PEG 2.71 65% evidence 8.5/20 RS sector -9.5% · RS bench 0.1% · 1Y -7.2%9 of 12 weeks ahead 100% evidence
Exact sum: 17.4 + 15.8 + 7.1 + 8.5 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Cloudflare, Inc.NET 48.8/100Mixed-negative evidence61% evidence BREAKING OUT 18.0/35 Revenue 31.6% · PAT — · OPM change 1.4 pp 62% evidence 3.5/25 ROCE -1.9% · OPM -9.7% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 17.3/20 RS sector 14.6% · RS bench 26.9% · 1Y 47.3%8 of 12 weeks ahead 100% evidence
Exact sum: 18 + 3.5 + 10 + 17.3 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Twilio Inc.TWLO 47.7/100Mixed-negative evidence64% evidence FADING 18.5/35 Revenue 15.6% · PAT — · OPM change 5.7 pp 62% evidence 8.5/25 ROCE 1.2% · OPM 7.7% 76% evidence 8.8/20 P/E 196.6× · PEG — 15% evidence 11.9/20 RS sector 10.6% · RS bench 22.8% · 1Y 96.7%10 of 12 weeks ahead 100% evidence
Exact sum: 18.5 + 8.5 + 8.8 + 11.9 = 47.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Akamai Technologies, Inc.AKAM 45.7/100Mixed-negative evidence81% evidence FADING 10.0/35 Revenue 6.1% · PAT -4% · OPM change -4.5 pp 83% evidence 11.6/25 ROCE 1.2% · OPM 10.7% 76% evidence 15.2/20 P/E 38.7× · PEG 0.7 65% evidence 8.9/20 RS sector -0.7% · RS bench 10.8% · 1Y 74.9%8 of 12 weeks ahead 100% evidence
Exact sum: 10 + 11.6 + 15.2 + 8.9 = 45.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
20MongoDB, Inc.MDB 44.8/100Mixed-negative evidence64% evidence BREAKING OUT 20.9/35 Revenue 23.7% · PAT — · OPM change 6.2 pp 71% evidence 5.0/25 ROCE -0.8% · OPM -3.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.9/20 RS sector -6.3% · RS bench 4.2% · 1Y 81.7%10 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 5 + 10 + 8.9 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Check Point Software Technologies Ltd.CHKP 43.3/100Thin evidence · provisional58% evidence TURNING 13.9/35 Revenue — · PAT — · OPM change -3 pp 45% evidence 14.2/25 ROCE 3.8% · OPM 27.7% 76% evidence 11.2/20 P/E 13.5× · PEG — 15% evidence 4.0/20 RS sector -39.5% · RS bench -32.8% · 1Y -32.4%1 of 12 weeks ahead 100% evidence
Exact sum: 13.9 + 14.2 + 11.2 + 4 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Oracle CorporationORCL 42.2/100Mixed-negative evidence85% evidence ASLEEP 16.1/35 Revenue 17.4% · PAT 37.3% · OPM change -0.1 pp 95% evidence 13.1/25 ROCE 3.4% · OPM 32% 76% evidence 12.4/20 P/E 38.7× · PEG 1.13 65% evidence 0.6/20 RS sector -39.7% · RS bench -33.5% · 1Y -41.7%5 of 12 weeks ahead 100% evidence
Exact sum: 16.1 + 13.1 + 12.4 + 0.6 = 42.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Palo Alto Networks, Inc.PANW 40.1/100Mixed-negative evidence85% evidence LEADER 7.9/35 Revenue 19.5% · PAT -31.9% · OPM change -15.7 pp 95% evidence 6.8/25 ROCE -0.7% · OPM -6.1% 76% evidence 5.5/20 P/E 147× · PEG 2.62 65% evidence 19.9/20 RS sector 40.1% · RS bench 54.3% · 1Y 119.3%12 of 12 weeks ahead 100% evidence
Exact sum: 7.9 + 6.8 + 5.5 + 19.9 = 40.1 · Decision use: Price leads the evidence: RS versus the benchmark is 54.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
24Zscaler, Inc.ZS 35.8/100Mixed-negative evidence64% evidence FADING 16.4/35 Revenue 24.6% · PAT — · OPM change 0.2 pp 71% evidence 4.5/25 ROCE -0.9% · OPM -3.5% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 4.9/20 RS sector -35.7% · RS bench -29.3% · 1Y -39.5%3 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 4.5 + 10 + 4.9 = 35.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25CoreWeave, Inc.CRWV 33.9/100Adverse evidence61% evidence ASLEEP 16.0/35 Revenue 100% · PAT — · OPM change -4.2 pp 62% evidence 5.4/25 ROCE -0.5% · OPM -6.9% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 2.5/20 RS sector -23.5% · RS bench -15.1% · 1Y -29.1%6 of 12 weeks ahead 100% evidence
Exact sum: 16 + 5.4 + 10 + 2.5 = 33.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Block, Inc.XYZ 31.0/100Adverse evidence71% evidence BREAKING OUT 5.2/35 Revenue 2.3% · PAT -68.8% · OPM change -8.5 pp 83% evidence 6.5/25 ROCE -0.6% · OPM -2.8% 76% evidence 9.6/20 P/E 47× · PEG — 15% evidence 9.7/20 RS sector -1.2% · RS bench 9.4% · 1Y 15.3%9 of 12 weeks ahead 100% evidence
Exact sum: 5.2 + 6.5 + 9.6 + 9.7 = 31 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Synopsys, Inc.SNPS 30.4/100Adverse evidence85% evidence ASLEEP 10.3/35 Revenue 39.5% · PAT -41.8% · OPM change -18.2 pp 95% evidence 9.8/25 ROCE 0.4% · OPM 5.3% 76% evidence 8.4/20 P/E 111.7× · PEG 1.75 65% evidence 1.9/20 RS sector -29.2% · RS bench -21.4% · 1Y -34.8%1 of 12 weeks ahead 100% evidence
Exact sum: 10.3 + 9.8 + 8.4 + 1.9 = 30.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Cerebras Systems Inc.CBRS 49.8/100Thin evidence · provisional41% evidence 25.6/35 Revenue 86.1% · PAT — · OPM change 20.8 pp 62% evidence 4.2/25 ROCE -0.9% · OPM -7.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 25.6 + 4.2 + 10 + 10 = 49.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Nutanix, Inc.'s stock price today?

Nutanix, Inc. trades at $61.5, −14.7% over the past year. The company is valued at $17.0 B. The stock sits at 60% of its 52-week range of $34–$79, +25.1% versus its 200-day average. On the tape, the price is topping out, 6 weeks in. — as of 5 August 2026.

What were Nutanix, Inc.'s latest quarterly results?

Nutanix, Inc. reported revenue of $0.4 B and net profit of $0.1 B for the Apr 26 quarter. Revenue rose 2.9% and profit rose 16.7% year on year. Earnings per share were $0.25. The operating margin was 19.4%, 5.1 pp higher than a year earlier. — as of 5 August 2026.

What is Nutanix, Inc.'s revenue?

Nutanix, Inc. reported revenue of $0.4 B in the Apr 26 quarter, +2.9% year on year. For the full FY25 fiscal year, revenue was $2.5 B (+18.1%). Over the last 4 years revenue compounded at 16.3% a year. — as of 5 August 2026.

What is Nutanix, Inc.'s profit?

Nutanix, Inc. earned $0.1 B of net profit in the Apr 26 quarter, +16.7% year on year — the 3rd straight quarter of growth. Full-year FY25 profit was $0.2 B. The operating margin ran 19.4% in the latest quarter. — as of 5 August 2026.

What is Nutanix, Inc.'s market cap?

Nutanix, Inc.'s market capitalisation is $17.0 B at a stock price of $61.5. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is Nutanix, Inc.'s P/E ratio?

Nutanix, Inc. trades at a P/E of 64.4×, at the 59th percentile of its own 1-year range, against a long-run median of 59.5×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does Nutanix, Inc. pay a dividend?

No — Nutanix, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.

Is Nutanix, Inc. overvalued?

On its own history, Nutanix, Inc. looks mid-range against its own history: its P/E of 64.4× sits at the 59th percentile of its 1-year range (long-run median 59.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.

Is Nutanix, Inc. growing?

Yes — Nutanix, Inc. is growing: latest-quarter revenue +2.9% year on year, profit +16.7%, and the margin +5.1 pp at 19.4%. The earnings engine currently reads: improving — as of 5 August 2026.

How is Nutanix, Inc. performing?

Nutanix, Inc. is topping out, 6 weeks in. Its latest quarter's revenue rose 2.9% and profit rose 16.7% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 15 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

Is Nutanix, Inc. in an uptrend?

It is stalling — the price is topping out (week 6 of stage 3), trading +25.1% versus its 200-day average and at 60% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.

Is Nutanix, Inc. beating the market?

On recent form, yes — Nutanix, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 15 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 9.8 years the stock moved +61% against the S&P 500's +259% — behind the index over the full window. — as of 5 August 2026.

Will Nutanix, Inc.'s stock price go up?

This page publishes no price forecast for Nutanix, Inc. What it measures instead: the stock price is $61.5, the price is topping out 6 weeks in. Its P/E of 64.4× sits at the 59th percentile of its own 1-year range. Direction is not something this site claims to know. — as of 5 August 2026.

Is the market betting against Nutanix, Inc.?

Yes — short interest is 10.3% of Nutanix, Inc.'s tradable float, about 6.5 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

What is Nutanix, Inc.'s capex?

Nutanix, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.1 B. — as of 5 August 2026.

What is Nutanix, Inc.'s cash flow?

Nutanix, Inc. generated $0.8 B of operating cash flow in FY25 and $0.8 B of free cash flow after $0.1 B of capital spending. Reported profit that year was $0.2 B, so operating cash ran ahead of profit. — as of 5 August 2026.

How financially safe is Nutanix, Inc.?

On the balance sheet, the Z-score reads 1.76 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.

Where is Nutanix, Inc. in its business cycle?

Nutanix, Inc.'s FY25 operating margin was 6.7%, against a 5-year band of −47.5%–6.7%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 19.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the Nutanix, Inc. story?

Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is Nutanix, Inc. a stock worth studying right now?

This is not investment advice. The machine read: Nutanix, Inc.'s balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI